185 related articles for article (PubMed ID: 24286874)
21. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis].
Afentaki A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386
[TBL] [Abstract][Full Text] [Related]
22. [The challenge of administering anti-tuberculosis treatment in infants and pre-school children. pTBred Magistral Project].
Piñeiro Pérez R; Santiago García B; Fernández Llamazares CM; Baquero Artigao F; Noguera Julian A; Mellado Peña MJ;
An Pediatr (Barc); 2016 Jul; 85(1):4-12. PubMed ID: 26364849
[TBL] [Abstract][Full Text] [Related]
23. Off label use of prescription medicines in children in outpatient setting in Estonia is common.
Lass J; Irs A; Pisarev H; Leinemann T; Lutsar I
Pharmacoepidemiol Drug Saf; 2011 May; 20(5):474-81. PubMed ID: 21416552
[TBL] [Abstract][Full Text] [Related]
24. Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital.
Kannan S; Bahl A; Khosla PP
Int J Risk Saf Med; 2015; 27(4):219-23. PubMed ID: 26756895
[TBL] [Abstract][Full Text] [Related]
25. Off-label prescribing patterns of antidepressants in children and adolescents.
Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
[TBL] [Abstract][Full Text] [Related]
26. Off-label drug prescribing in a Portuguese paediatric emergency unit.
Ribeiro M; Jorge A; Macedo AF
Int J Clin Pharm; 2013 Feb; 35(1):30-6. PubMed ID: 23054136
[TBL] [Abstract][Full Text] [Related]
27. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
28. The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals.
Marchetti F; Bua J; Ventura A; Notarangelo LD; Di Maio S; Migliore G; Bonati M
Eur J Clin Pharmacol; 2007 Jan; 63(1):81-5. PubMed ID: 17124577
[TBL] [Abstract][Full Text] [Related]
29. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
[TBL] [Abstract][Full Text] [Related]
30. The attitude of Flemish paediatricians regarding informed consent of adolescents.
Deneyer M; Otten J; Marchand J; Buyl R; Clybouw C; Vandenplas Y
Acta Clin Belg; 2013; 68(1):43-7. PubMed ID: 23627194
[TBL] [Abstract][Full Text] [Related]
31. [Has the use of antipyretics been modified after the introduction of different concentrations of ibuprofen into the market?].
García Blanes CP; Rodríguez-Cantón Pascual P; Morales-Carpi C; Morales-Olivas FJ
An Pediatr (Barc); 2014 Dec; 81(6):383-8. PubMed ID: 24629903
[TBL] [Abstract][Full Text] [Related]
32. Age-related off-label use of nasal corticosteroids for allergies is relatively common in Finnish children with asthma.
Sonninen K; Jyrkkä J; Martikainen JE; Malmström K; Mäkelä MJ; Sepponen K
Acta Paediatr; 2017 Nov; 106(11):1830-1836. PubMed ID: 28692177
[TBL] [Abstract][Full Text] [Related]
33. Off-label and unlicensed medicines to hospitalised children in Norway.
Teigen A; Wang S; Truong BT; Bjerknes K
J Pharm Pharmacol; 2017 Apr; 69(4):432-438. PubMed ID: 27334565
[TBL] [Abstract][Full Text] [Related]
34. Off-label prescriptions in Italian hospices: a national survey.
Toscani F; Di Giulio P; Campi R; Pellerin I; De Luca A; Casale G;
J Pain Symptom Manage; 2009 Sep; 38(3):365-71. PubMed ID: 19564095
[TBL] [Abstract][Full Text] [Related]
35. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
[TBL] [Abstract][Full Text] [Related]
36. Off-label prescribing in pediatric outpatients.
Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
[TBL] [Abstract][Full Text] [Related]
37. Development of the Swiss Database for dosing medicinal products in pediatrics.
Tilen R; Panis D; Aeschbacher S; Sabine T; Meyer Zu Schwabedissen HE; Berger C
Eur J Pediatr; 2022 Mar; 181(3):1221-1231. PubMed ID: 34739591
[TBL] [Abstract][Full Text] [Related]
38. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
39. [Are we prepared for a disaster? Spanish multicentre study].
Parra Cotanda C; Asensio Carretero S; Trenchs Sainz de la Maza V; Luaces Cubells C;
An Pediatr (Barc); 2012 Sep; 77(3):158-64. PubMed ID: 22361047
[TBL] [Abstract][Full Text] [Related]
40. [Antimicrobial prophylaxis for caesarean delivery: changes in practice and administration before incision, feasibility study to paediatricians in Auvergne].
Rambourdin M; Bonnin M; Storme B; Brunhes A; Boeuf B; Kauffmann S; Pinheiro H; Vernis L; Lavergne B; Gallot D; Vendittelli F; Bazin JE
Ann Fr Anesth Reanim; 2013 Jan; 32(1):12-7. PubMed ID: 23199847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
